Advances in clinical trial design for development of new TB treatments: A call for innovation

PLoS Med. 2019 Mar 22;16(3):e1002769. doi: 10.1371/journal.pmed.1002769. eCollection 2019 Mar.

Authors

Christian Lienhardt¹, Payam Nahid²

Affiliations

¹ Unité Mixte Internationale TransVIHMI (UMI 233 IRD-U1175 INSERM, Université de Montpellier), Institut de Recherche pour le Développement (IRD), Montpellier, France.
² Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, California, United States of America.

Abstract

Christian Lienhardt and Payam Nahid launch the Collection on Advances in Clinical Trial Design for Development of New Tuberculosis Treatments.

Publication types

Editorial

MeSH terms

Antitubercular Agents / pharmacology
Antitubercular Agents / therapeutic use*
Clinical Trials as Topic / methods*
Humans
Mycobacterium tuberculosis / drug effects
Mycobacterium tuberculosis / physiology
Research Design / trends
Therapies, Investigational / methods*
Therapies, Investigational / trends
Tuberculosis / diagnosis
Tuberculosis / drug therapy*
Tuberculosis / epidemiology

Substances

Antitubercular Agents

Grants and funding

The authors received no specific funding for this work.